Metastatic Colorectal Carcinoma

Also known as: Stage IV Colorectal Cancer / Colorectal Cancer Stage IV / Colorectal cancer Dukes D

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB08885	Aflibercept	1	Active Not Recruiting	1
DB00041	Aldesleukin	1	Terminated	1
DB11794	Berzosertib	1	Active Not Recruiting	1
DB00112	Bevacizumab	1	Active Not Recruiting	2
DB11967	Binimetinib	1	Terminated	1
DB01373	Calcium	1	Active Not Recruiting	3
DB01373	Calcium	1	Completed	1
DB04690	Camptothecin	1	Active Not Recruiting	3
DB01101	Capecitabine	1	Recruiting	1
DB00002	Cetuximab	1	Active Not Recruiting	1
DB14547	Chloride ion	1	Recruiting	1
DB00515	Cisplatin	1	Recruiting	1
DB00531	Cyclophosphamide	1	Terminated	1
DB01254	Dasatinib	1	Active Not Recruiting	1
DB00694	Daunorubicin	1	Recruiting	1
DB00997	Doxorubicin	1	Recruiting	1
DB11714	Durvalumab	1	Completed	1
DB11718	Encorafenib	1	Terminated	1
DB00544	Fluorouracil	1	Active Not Recruiting	3
DB00544	Fluorouracil	1	Recruiting	2
DB00142	Glutamic acid	1	Active Not Recruiting	1
DB05382	Iodine	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Completed	1
DB00762	Irinotecan	1	Active Not Recruiting	3
DB00762	Irinotecan	1	Recruiting	1
DB00650	Leucovorin	1	Active Not Recruiting	3
DB00650	Leucovorin	1	Recruiting	1
DB11596	Levoleucovorin	1	Active Not Recruiting	3
DB00305	Mitomycin	1	Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Terminated	1
DB00526	Oxaliplatin	1	Active Not Recruiting	2
DB00526	Oxaliplatin	1	Recruiting	2
DB09037	Pembrolizumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Completed	1
DB09037	Pembrolizumab	1	Terminated	1
DB12257	Platinum	1	Recruiting	1
DB08896	Regorafenib	1	Active Not Recruiting	1
DB00740	Riluzole	1	Active Not Recruiting	1
DB08937	TAS-102	1	Completed	2
DB09343	Tipiracil	1	Completed	2
DB08911	Trametinib	1	Completed	1
DB11771	Tremelimumab	1	Completed	1
DB00432	Trifluridine	1	Completed	2
DB15113	Utomilumab	1	Active Not Recruiting	1
DB12981	XL-888	1	Completed	1
DB12001	Abemaciclib	1 / 2	Active Not Recruiting	1
DB00126	Ascorbic acid	1 / 2	Terminated	1
DB00112	Bevacizumab	1 / 2	Completed	1
DB00112	Bevacizumab	1 / 2	Terminated	1
DB16680	Cadonilimab	1 / 2	Recruiting	1
DB01373	Calcium	1 / 2	Active Not Recruiting	1
DB04690	Camptothecin	1 / 2	Terminated	1
DB01101	Capecitabine	1 / 2	Completed	1
DB00002	Cetuximab	1 / 2	Active Not Recruiting	1
DB00544	Fluorouracil	1 / 2	Active Not Recruiting	1
DB00544	Fluorouracil	1 / 2	Terminated	1
DB11896	Gedatolisib	1 / 2	Terminated	1
DB00619	Imatinib	1 / 2	Completed	1
DB00762	Irinotecan	1 / 2	Active Not Recruiting	1
DB00762	Irinotecan	1 / 2	Recruiting	1
DB00762	Irinotecan	1 / 2	Terminated	2
DB00650	Leucovorin	1 / 2	Active Not Recruiting	1
DB00650	Leucovorin	1 / 2	Terminated	1
DB11596	Levoleucovorin	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB00526	Oxaliplatin	1 / 2	Completed	1
DB12332	Rucaparib	1 / 2	Active Not Recruiting	1
DB17380	Saposin C	1 / 2	Recruiting	1
DB08937	TAS-102	1 / 2	Recruiting	1
DB09343	Tipiracil	1 / 2	Recruiting	1
DB00432	Trifluridine	1 / 2	Recruiting	1
DB11595	Atezolizumab	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Active Not Recruiting	1
DB11967	Binimetinib	2	Active Not Recruiting	1
DB01101	Capecitabine	2	Active Not Recruiting	1
DB01101	Capecitabine	2	Not Yet Recruiting	1
DB00002	Cetuximab	2	Recruiting	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB00531	Cyclophosphamide	2	Terminated	1
DB12109	Devimistat	2	Recruiting	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB11714	Durvalumab	2	Recruiting	1
DB11718	Encorafenib	2	Recruiting	1
DB00544	Fluorouracil	2	Completed	2
DB00544	Fluorouracil	2	Recruiting	1
DB11679	Fruquintinib	2	Not Yet Recruiting	1
DB00441	Gemcitabine	2	Recruiting	1
DB01611	Hydroxychloroquine	2	Recruiting	2
DB00762	Irinotecan	2	Completed	2
DB00650	Leucovorin	2	Completed	2
DB00166	Lipoic acid	2	Recruiting	1
DB00331	Metformin	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	2
DB09035	Nivolumab	2	Recruiting	1
DB00526	Oxaliplatin	2	Active Not Recruiting	1
DB09073	Palbociclib	2	Active Not Recruiting	1
DB01269	Panitumumab	2	Active Not Recruiting	1
DB01269	Panitumumab	2	Completed	2
DB01269	Panitumumab	2	Recruiting	1
DB15102	Pemigatinib	2	Active Not Recruiting	1
DB08896	Regorafenib	2	Active Not Recruiting	1
DB08896	Regorafenib	2	Recruiting	1
DB08937	TAS-102	2	Active Not Recruiting	3
DB09343	Tipiracil	2	Active Not Recruiting	3
DB11771	Tremelimumab	2	Active Not Recruiting	1
DB00432	Trifluridine	2	Active Not Recruiting	3
DB00002	Cetuximab	2 / 3	Completed	1
DB00544	Fluorouracil	2 / 3	Completed	1
DB00762	Irinotecan	2 / 3	Completed	1
DB00650	Leucovorin	2 / 3	Completed	1
DB00112	Bevacizumab	3	Not Yet Recruiting	1
DB00112	Bevacizumab	3	Recruiting	1
DB01101	Capecitabine	3	Recruiting	1
DB00002	Cetuximab	3	Not Yet Recruiting	1
DB00322	Floxuridine	3	Not Yet Recruiting	1
DB00544	Fluorouracil	3	Not Yet Recruiting	1
DB00762	Irinotecan	3	Not Yet Recruiting	1
DB00650	Leucovorin	3	Not Yet Recruiting	1
DB00526	Oxaliplatin	3	Not Yet Recruiting	1
DB00526	Oxaliplatin	3	Recruiting	1
DB01269	Panitumumab	3	Not Yet Recruiting	1
DB15765	Sintilimab	3	Recruiting	1
DB00544	Fluorouracil	4	Unknown Status	1
DB00762	Irinotecan	4	Unknown Status	1
DB00650	Leucovorin	4	Unknown Status	1
DB00806	Pentoxifylline	4	Not Yet Recruiting	1
DB00002	Cetuximab	Not Available	Recruiting	1
DB11718	Encorafenib	Not Available	Recruiting	1
DB00693	Fluorescein	Not Available	Completed	1
DB00936	Salicylic acid	Not Available	Not Yet Recruiting	1